MEETINGS - Molecular & Genetic Diagnostics: Profiting from Novel Diagnostics that Assess Disease Risk, Disease Presence & Treatment Response (UK) October 1999:
This article was originally published in Clinica
Executive Summary
IBC Conferences will hold a meeting on Molecular & Genetic Diagnostics: Profiting from Novel Diagnostics that Assess Disease Risk, Disease Presence & Treatment Response in London on October 4-5. Dr Uwe Bicker, executive chairman and director of Dade Behring and president of the European Diagnostic Manufacturers Association (EDMA), will present the keynote speech on growth & shift in the diagnostics industry. Representatives from companies including Roche Molecular Systems, Shield Diagnostics and Nycomed Amersham Imaging will discuss some of the latest developments in this field. For more details contact IBC in the UK. Tel: +44 20 7453 5496. Fax: +44 20 7636 6858. Website: www.ibc-uk.com/it1135
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.